Short answer · Medically reviewed summary · Last updated: 2026-05-08
Treatment for glioma is highly personalized, typically involving a combination of surgical resection, radiation therapy, and chemotherapy tailored to the tumor’s grade and molecular profile. While there is no single cure, these standard interventions aim to manage symptoms, slow tumor progression, and improve quality of life for those living with the condition. What are the primary medical treatments for glioma? The standard of care for glioma usually follows the "Stupp protocol" for high-grade tumors, which combines maximal safe surgical resection followed by concurrent radiation and chemotherapy.
1 people with Glioma have shared their first-person experience on this question at DiseaseMaps.
Treatment for glioma is highly personalized, typically involving a combination of surgical resection, radiation therapy, and chemotherapy tailored to the tumor’s grade and molecular profile. While there is no single cure, these standard interventions aim to manage symptoms, slow tumor progression, and improve quality of life for those living with the condition.
The standard of care for glioma usually follows the "Stupp protocol" for high-grade tumors, which combines maximal safe surgical resection followed by concurrent radiation and chemotherapy. The most common chemotherapy agent used is temozolomide (Temodar). For lower-grade glioma, treatment may involve more conservative monitoring or surgery followed by adjuvant therapy depending on the tumor's genetic markers, such as IDH mutation status and 1p/19q codeletion.
Managing glioma requires a coordinated effort between several specialists to address both the physical tumor and the patient's neurological function. Your care team should ideally include:
Research into glioma is rapidly evolving. Current clinical trials are investigating immunotherapy (such as checkpoint inhibitors), tumor-treating fields (Optune), and targeted therapies based on specific genetic mutations. Because glioma behavior varies significantly between individuals, patients are encouraged to discuss biomarker-driven clinical trials with their oncology team.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult your personal healthcare provider regarding treatment decisions.